Stem Cell Revolution
In this episode of Stem Cell Revolution, Donna Chang and Jan Shultis examine President Trump’s executive order accelerating psychedelic therapies for serious mental health conditions. They review the historic Oval Office signing, the roles of the FDA and DEA in drug scheduling, and the groundswell of public support—including voices like Joe Rogan and Secretary Kennedy—that helped bring the issue to national attention.The conversation explores how Schedule I substances like MDMA and LSD have been restricted from research and what rescheduling could mean for patient access and clinical trials. Donna and Jan break down Right to Try pathways, overseas treatment experiences, and the balance between safety, dependency risks, and therapeutic potential.This thoughtful discussion offers viewers a scientifically grounded look at how policy changes in one field may inform progress in stem cell research. It underscores the shared need for evidence-based evolution that prioritizes rigorous science while expanding access to promising therapies for chronic conditions.Learn MoreWebsite: https://www.hope.bio/X (Twitter): @hopebiosciencesInstagram: @hope.bioFacebook: https://www.facebook.com/share/1Qk9jgqq8W/?mibextid=wwXIfrLinkedIn: https://www.linkedin.com/company/hopebio/YouTube Channel: https://www.youtube.com/@hopebiosciences#StemCells #RegenerativeMedicine #PsychedelicTherapy #MentalHealth #RegulatoryReform #StemCellResearch #FutureOfMedicine #Biotechnology
29 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de Stem Cell Revolution!